chr3-128480819-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032638.5(GATA2):​c.*200C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.228 in 582,460 control chromosomes in the GnomAD database, including 16,277 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4035 hom., cov: 33)
Exomes 𝑓: 0.23 ( 12242 hom. )

Consequence

GATA2
NM_032638.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.342

Publications

9 publications found
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
GATA2 Gene-Disease associations (from GenCC):
  • deafness-lymphedema-leukemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • GATA2 deficiency with susceptibility to MDS/AML
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • monocytopenia with susceptibility to infections
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • myelodysplastic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-128480819-G-A is Benign according to our data. Variant chr3-128480819-G-A is described in ClinVar as Benign. ClinVar VariationId is 343127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATA2NM_032638.5 linkc.*200C>T 3_prime_UTR_variant Exon 6 of 6 ENST00000341105.7 NP_116027.2 P23769-1
GATA2NM_001145661.2 linkc.*200C>T 3_prime_UTR_variant Exon 7 of 7 NP_001139133.1 P23769-1
GATA2NM_001145662.1 linkc.*200C>T 3_prime_UTR_variant Exon 6 of 6 NP_001139134.1 P23769-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATA2ENST00000341105.7 linkc.*200C>T 3_prime_UTR_variant Exon 6 of 6 1 NM_032638.5 ENSP00000345681.2 P23769-1

Frequencies

GnomAD3 genomes
AF:
0.224
AC:
34115
AN:
152064
Hom.:
4031
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.291
Gnomad AMR
AF:
0.232
Gnomad ASJ
AF:
0.215
Gnomad EAS
AF:
0.136
Gnomad SAS
AF:
0.104
Gnomad FIN
AF:
0.222
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.257
Gnomad OTH
AF:
0.241
GnomAD4 exome
AF:
0.230
AC:
98915
AN:
430278
Hom.:
12242
Cov.:
5
AF XY:
0.225
AC XY:
49843
AN XY:
221842
show subpopulations
African (AFR)
AF:
0.190
AC:
2338
AN:
12328
American (AMR)
AF:
0.238
AC:
3613
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
2871
AN:
12968
East Asian (EAS)
AF:
0.131
AC:
3881
AN:
29668
South Asian (SAS)
AF:
0.109
AC:
3397
AN:
31146
European-Finnish (FIN)
AF:
0.222
AC:
7015
AN:
31660
Middle Eastern (MID)
AF:
0.273
AC:
522
AN:
1914
European-Non Finnish (NFE)
AF:
0.256
AC:
69250
AN:
270408
Other (OTH)
AF:
0.241
AC:
6028
AN:
24978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4027
8055
12082
16110
20137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.224
AC:
34132
AN:
152182
Hom.:
4035
Cov.:
33
AF XY:
0.221
AC XY:
16435
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.192
AC:
7950
AN:
41514
American (AMR)
AF:
0.232
AC:
3548
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
747
AN:
3472
East Asian (EAS)
AF:
0.136
AC:
701
AN:
5170
South Asian (SAS)
AF:
0.105
AC:
507
AN:
4826
European-Finnish (FIN)
AF:
0.222
AC:
2346
AN:
10588
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.257
AC:
17483
AN:
68000
Other (OTH)
AF:
0.239
AC:
504
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1383
2766
4150
5533
6916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.248
Hom.:
2471
Bravo
AF:
0.228
Asia WGS
AF:
0.133
AC:
466
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Deafness-lymphedema-leukemia syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.53
DANN
Benign
0.59
PhyloP100
-0.34
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10934857; hg19: chr3-128199662; API